MetaCap

ClearPoint Neuro Statistics

NASDAQ: CLPTHealth CareMedical/Dental InstrumentsUSD

6.91-0.40 (-5.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ClearPoint Neuro by the numbers

ClearPoint Neuro has a market capitalization of $221.5 million based on 32.05M shares outstanding. With trailing EPS of $-1.21, ClearPoint Neuro is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.0% below its 50-day average and 45.0% below its 200-day average.

Average daily trading volume is 701.64K shares, or about $4.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLPT valuation vs. peer median

CLPT compared with the median of 8 peer companies
MetricCLPTPeer medianDifference
Market cap$221.49M$218.35M+1%
Avg. volume701.64K95.93K+631%

Peer median across 8 companies: PROF, OSUR, KTWO, PDEX, UTMD, OFIX, SSII, ANIK.

Valuation

Market cap
$221.49M
Price / sales (latest FY)
5.99
EPS (TTM)
$-1.21

Price and trading

Previous close
7.31
Open
7.15
Day range
6.85 – 7.45
52-week range
6.85 – 19.63
52-week change
-50.00%
Beta
—
Volume
1.11M

Dividends and events

Annual dividend
None
Next earnings date
Oct 28, 2026

Additional statistics

Market Cap
221.49M
Forward Pe
-7.51
Eps
-1.21
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
19.63
Week52 Low
6.85
Avg Volume
701.64K
Shares Outstanding
32.05M
Ma50
10.63
Ma200
12.57
Earnings Date
Oct 28, 2026
Pct From52w High
-64.80%
Pct From52w Low
0.88%

Related